Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach

by Simran Venkatraman, Brinda Balasubramanian, Pisut Pongchaikul, Rutaiwan Tohtong, Somchai Chutipongtanate
Published 2022

Rtk25: A comprehensive molecular profiling strategy in cholangiocarcinoma using an integrated bioinformatics approach

by Brinda Balasubramanian, Simran Venkatraman, Tavan Janvilisri, Tuangporn Suthiphongchai, Siriporn Jitkaew, Jittiyawadee Sripa, Rutaiwan Tohtong
Published 2022

Co-clinical trials: An innovative drug development platform for cholangiocarcinoma

by Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Tavan Janvilisri, Kanokpan Wongprasert, Supeecha Kumkate, David O. Bates, Rutaiwan Tohtong
Published 2022

Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker

by Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Janpen Puetkasichonpasutha, Rutaiwan Tohtong, Nisana Namwat, Prakasit Sa-Ngiamwibool, Attapol Titapun, Tuangporn Suthiphongchai
Published 2022

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

by Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M. Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M. Grabowska, David O. Bates, Kanokpan Wongprasert
Published 2022